KYMR Stock Price
Kymera Therapeutics, Inc.
KYMR stock price is $107.27 (+0.41% on the day), giving Kymera Therapeutics, Inc. a market cap of $8.88B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
KYMR Stock Overview
- Price
- $107.27
- Previous close
- $106.83
- Open
- $106.75
- Market cap
- $8.88B
- P/E ratio
- -28.5
- 52-week range
- $55.26 - $130.05
- 1-year price target
- $138.58
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 43
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., together with its subsidiary, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis. The company develops STAT6, a Type 2 inflammation in allergic diseases; and TYK2, a treatment for inflammatory bowel disease, which are in Phase I and IND-enabling respectively. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $107.27 | +0.4% | 243.33K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW